These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging. Mielke MM; Hagen CE; Wennberg AMV; Airey DC; Savica R; Knopman DS; Machulda MM; Roberts RO; Jack CR; Petersen RC; Dage JL JAMA Neurol; 2017 Sep; 74(9):1073-1080. PubMed ID: 28692710 [TBL] [Abstract][Full Text] [Related]
5. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment. Fei M; Jianghua W; Rujuan M; Wei Z; Qian W J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911 [TBL] [Abstract][Full Text] [Related]
6. Is periodontitis a risk factor for cognitive impairment and dementia? A case-control study. Gil-Montoya JA; Sanchez-Lara I; Carnero-Pardo C; Fornieles F; Montes J; Vilchez R; Burgos JS; Gonzalez-Moles MA; Barrios R; Bravo M J Periodontol; 2015 Feb; 86(2):244-53. PubMed ID: 25345338 [TBL] [Abstract][Full Text] [Related]
8. Blood amyloid levels and risk of dementia in the Ginkgo Evaluation of Memory Study (GEMS): A longitudinal analysis. Lopez OL; Chang Y; Ives DG; Snitz BE; Fitzpatrick AL; Carlson MC; Rapp SR; Williamson JD; Tracy RP; DeKosky ST; Kuller LH Alzheimers Dement; 2019 Aug; 15(8):1029-1038. PubMed ID: 31255494 [TBL] [Abstract][Full Text] [Related]
9. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition. Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509 [TBL] [Abstract][Full Text] [Related]
10. Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease. González-Martínez Á; Rosado B; Pesini P; Suárez ML; Santamarina G; García-Belenguer S; Villegas A; Monleón I; Sarasa M Exp Gerontol; 2011 Jul; 46(7):590-6. PubMed ID: 21377518 [TBL] [Abstract][Full Text] [Related]
11. Several direct and calculated biomarkers from the amyloid-β pool in blood are associated with an increased likelihood of suffering from mild cognitive impairment. Pérez-Grijalba V; Pesini P; Monleón I; Boada M; Tárraga L; Ruiz-Laza A; Martínez-Lage P; San-José I; Sarasa M J Alzheimers Dis; 2013; 36(1):211-9. PubMed ID: 23635404 [TBL] [Abstract][Full Text] [Related]
12. Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics. Moulin S; Leys D; Schraen-Maschke S; Bombois S; Mendyk AM; Muhr-Tailleux A; Cordonnier C; Buee L; Pasquier F; Bordet R Curr Alzheimer Res; 2017; 14(6):686-694. PubMed ID: 26502812 [TBL] [Abstract][Full Text] [Related]
13. Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy? Tholen S; Schmaderer C; Chmielewski S; Förstl H; Heemann U; Baumann M; Steubl D; Grimmer T J Alzheimers Dis; 2016; 50(3):791-6. PubMed ID: 26682683 [TBL] [Abstract][Full Text] [Related]
15. Interactions between amyloid-β and tau in cerebrospinal fluid of people with mild cognitive impairment and Alzheimer's disease. Kristofikova Z; Ricny J; Kolarova M; Vyhnalek M; Hort J; Laczo J; Sirova J; Ripova D J Alzheimers Dis; 2014; 42 Suppl 3():S91-8. PubMed ID: 24670397 [TBL] [Abstract][Full Text] [Related]
16. Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays. Lewczuk P; Lelental N; Spitzer P; Maler JM; Kornhuber J J Alzheimers Dis; 2015; 43(1):183-91. PubMed ID: 25079805 [TBL] [Abstract][Full Text] [Related]
17. Aβ1-17 is a major amyloid-β fragment isoform in cerebrospinal fluid and blood with possible diagnostic value in Alzheimer's disease. Pérez-Grijalba V; Pesini P; Allué JA; Sarasa L; Montañés M; Lacosta AM; Casabona D; San-José I; Boada M; Tárraga L; Ruiz A; Sarasa M J Alzheimers Dis; 2015; 43(1):47-56. PubMed ID: 25061046 [TBL] [Abstract][Full Text] [Related]
18. Systemic inflammatory impact of periodontitis on cognitive impairment. Gil Montoya JA; Barrios R; Sanchez-Lara I; Ramos P; Carnero C; Fornieles F; Montes J; Santana S; Luna JD; Gonzalez-Moles MA Gerodontology; 2020 Mar; 37(1):11-18. PubMed ID: 31347730 [TBL] [Abstract][Full Text] [Related]
19. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377 [TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]